Intuity Medical met it $5.5 million goal in a recent funding round, SEC filings show.

Sunnyvale, Calif.-based Intuity, a spin-off of research group Sarnoff Corporation, is working to simplify diabetes management. The company’s flagship product is the POGO blood glucose monitoring system, which integrates test strips and a lancing device into one system. The POGO technology currently has only investigational device classification, according to the company’s website.

Intuity attracted 17 unnamed investors to meet its mark, offering both equity and debt, according to a regulatory filing.